ResMed | RMD - Cash And Equivalent



ResMed reported $1.21B in Cash and Equivalent for its fiscal quarter ending in June of 2025.


Cash And Equivalent Change Date
Ansell USD 912.3M 747.2M Jun/2024
AtriCure USD 117.8M 17.91M Jun/2025
Baxter International USD 2.29B 530M Mar/2025
Cochlear AUD 383.1M 130.5M Dec/2024
Cooper Companies USD 124.9M 8.7M Jul/2025
CSL 1.52B 133M Dec/2024
Dexcom USD 1.16B 254.1M Jun/2025
Edwards Lifesciences USD 3.14B 95.4M Mar/2025
Fisher Paykel Healthcare NZD 264.5M 147.9M Mar/2025
Globus Medical USD 229.45M 231.82M Jun/2025
Haemonetics USD 292.9M 13.86M Jun/2025
Hologic USD 1.74B 305.7M Jun/2025
Idexx Laboratories USD 164.59M 624K Jun/2025
Insulet USD 1.12B 107M Jun/2025
Integra LifeSciences USD 217.91M 21.19M Jun/2025
Intuitive Surgical USD 9.53B 431.3M Jun/2025
Masimo USD 149.6M 18.8M Jun/2025
Medtronic USD 2.22B 978M Apr/2025
Philips EUR 1.82B 629M Jun/2025
Ramsay Health Care AUD 341.1M 321.2M Dec/2024
ResMed USD 1.21B 276.74M Jun/2025
Sigma Healthcare 16.65M 3.68M Jan/2023
Sonic Healthcare 645M 25.39M Jun/2024
Steris USD 279.7M 108M Jun/2025
Teleflex USD 253.7M 30.42M Jun/2025
Thermo Fisher Scientific USD 4.58B 442M Jun/2025